ROZROLIMUPAB
UNII S134V96RPQ

Substance Identification & Data

This profile provides standardized clinical and technical data for Rozrolimupab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S134V96RPQ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 909402-77-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
S134V96RPQ
CAS Registry Number
909402-77-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ROZROLIMUPAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
USAN ID
UU-166
Identifier assigned by the United States Adopted Names Council.
Substance Type
mixture
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rozrolimupab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ROZROLIMUPAB

Common Names & Synonyms

ANTI-RHD RECOMBINANT HUMAN POLYCLONAL ANTIBODY COMPRISED OF 25 UNIQUE IGG1 ANTIBODIES
ROZROLIMUPAB [USAN]
ROZROLIMUPAB [WHO-DD]

Technical Codes

SYM001
SYM-001